Comparison of three PCR techniques for detecting cytomegalovirus (CMV) DNA in serum, detection of early antigen fluorescent foci and culture for the diagnosis of CMV infection

Journal of Medical Microbiology

Volumn 48, Issue 11, 1999, Pages 1029-1035

  Evans, P C ^b   Gray, J J ^a   Wreghitt, T G ^a   Marcus, R E ^a   Alexander, G J M ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; INTERMETHOD COMPARISON; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; VIRUS DETECTION;

EID: 0033494480     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-11-1029     Document Type: Article

References (26)

1. 1. Glenn J. Cytomegalovirus infections following renal transplantation. Rev Infect Dis 1981; 3: 1151-1178.
2. 2. Singh N, Dummer JS, Kusne S et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and effect of OKT3 antibodies. J Infect Dis 1998; 158: 124-131.
3. 3. Sutherland S, Bracken P, Wreghitt TG, O'Grady J, Calne RY, Williams R. Donated organ as a source of cytomegalovirus in orthotopic liver transplantation. J Med Virol 1992; 37: 170-173.
4. 4. Wingard JR. Viral infections in leukemia and bone marrow transplant patients. Leuk Lymphoma 1993; 11: 115-125.
5. 5. Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus in liver transplant recipients: a randomized trial. Ann Intern Med 1994; 120: 375-381.
6. 6. Goodrich JM, Mori M, Gleaves CA et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 325: 1601-1607.
7. 7. Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993; 56: 330-334.
8. 8. Taylor-Wiedeman J, Sissons JGP, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991; 72: 2059-2064.
9. 9. Evans PC, Gray J, Wreghitt TG, Alexander GJM. Optimisation of the polymerase chain reaction and dot-blot hybridisation for detecting cytomegalovirus DNA in urine: comparison with detection of early antigen fluorescent foci and culture. J Virol Methods 1998; 73: 41-52.
10. 10. Rashtichian A. Novel methods for cloning and engineering genes using the polymerase chain reaction. Curr Opin Biotechnol 1995; 6: 30-36.
11. 11. Karet FE, Charnock-Jones S, Harrison-Woolrych ML et al. Quantification of mRNA in human tissue using fluorescent nested reverse-transcriptase polymerase chain reaction. Anal Biochem 1994; 220: 384-390.
12. 12 Zipeto D, Revello MG. Silini E et al. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J Clin Microbiol 1992; 30:527-530.
13. 13. Rawal BK, Booth JC, Fernando S, Butcher PD, Powles RL. Quantification of cytomegalovirus DNA in blood specimens from bone marrow transplant recipients by the polymerase chain reaction. J Virol Methods 1994; 47: 189-202.
14. 14. Gerna G, Zipeto D, Parea M et al. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia and DNAemia. J Infect Dis 1991; 164: 488-498.
15. 15. Kidd IM, Fox JC, Pillay D, Charman H, Griffiths PD, Emery VC. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation 1993; 56: 867-871.
16. 16. Delgado R, Lumbreras C, Alba C et al. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol 1992; 30: 1876-1878.
17. 17. Einsele H, Ehninger G, Steidle M et al. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 1991; 338: 1170-1172.
18. 18. Patel R, Smith TF, Espy M et al. Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol 1994; 32: 1431-1434.
19. 19. van Dorp WT, Vlieger A, Jiwa KM et al. The polymerase chain reaction, a sensitive and rapid technique for detecting cytomegalovirus infection after renal transplantation. Transplantation 1992; 54: 661-664.
20. 20. Prösch, S, Kimel V, Dawydowa I, Krüger DH. Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR. J Med Virol 1992; 38: 246-251.
21. 21. Jiwa NM, Raap AK, van de Rijke FM et al. Detection of cytomegalovirus antigens and DNA in tissues fixed in formaldehyde. J Clin Pathol 1989; 42: 749-754.
22. 22. Fox JC, Griffiths PD, Emery VC. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol 1992; 73: 2405-2408.
23. 23. Schäfer P, Braun RW, Möhring K et al. Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis. J Gen Virol 1993; 74: 2699-2707.
24. 24. Cone RW, Hobson AC, Huang M-LW. Coamplified positive control detects inhibition of polymerase chain reactions. J Clin Microbiol 1992; 30: 3185-3189.
25. 25. Gerna G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasm of transplant and AIDS patients. J Clin Microbiol 1994; 32: 2709-2717.
26. 26. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 9717-9721.